Kent Gordon

Techcyte, Inc. is a world leader in AI-based digital diagnostics for lab medicine. The company is based in Orem, UT and was founded in 2013 by Ralph Yarro and Mohamed E. Salama. Techcyte's clinical pathology AI platform uses deep machine learning to perform automated analysis of whole slide microscopy images, revolutionizing digital diagnostics for human, animal, and environmental clinics and labs. Techcyte's clinical pathology platform is for research use only in some locations. The company provides an AI software platform for clinical pathology that leverages machine learning for quicker, more efficient diagnoses for laboratories and patients. Ralph Yarro has been the CEO since 2013.

Techcyte, Inc. is a world leader in AI-based digital diagnostics for lab medicine. The company is based in Orem, UT and was founded in 2013 by Ralph Yarro and Mohamed E. Salama. Techcyte's clinical pathology AI platform uses deep machine learning to perform automated analysis of whole slide microscopy images, revolutionizing digital diagnostics for human, animal, and environmental clinics and labs. Techcyte's clinical pathology platform is for research use only in some locations. The company provides an AI software platform for clinical pathology that leverages machine learning for quicker, more efficient diagnoses for laboratories and patients. Ralph Yarro has been the CEO since 2013.

NanoSpot ai, Inc is a company that provides a point-of-care and home testing platform using agglutination and artificial intelligence-based interpretation. The company is based in Salt Lake City, UT. The company's innovative test accurately detects the levels of COVID antibodies in just a few minutes, pain-free, and affordably priced. The test allows anyone to access the levels of their COVID antibodies via a phone screen. The company was founded in 2022 by Hans Haecker, Vanessa Redecke, Mark E. Astill. Rian Wendling has been the CEO of the company since 2021.

Techcyte, Inc. is a world leader in AI-based digital diagnostics for lab medicine. The company is based in Orem, UT and was founded in 2013 by Ralph Yarro and Mohamed E. Salama. Techcyte's clinical pathology AI platform uses deep machine learning to perform automated analysis of whole slide microscopy images, revolutionizing digital diagnostics for human, animal, and environmental clinics and labs. Techcyte's clinical pathology platform is for research use only in some locations. The company provides an AI software platform for clinical pathology that leverages machine learning for quicker, more efficient diagnoses for laboratories and patients. Ralph Yarro has been the CEO since 2013.

Techcyte, Inc. is a world leader in AI-based digital diagnostics for lab medicine. The company is based in Orem, UT and was founded in 2013 by Ralph Yarro and Mohamed E. Salama. Techcyte's clinical pathology AI platform uses deep machine learning to perform automated analysis of whole slide microscopy images, revolutionizing digital diagnostics for human, animal, and environmental clinics and labs. Techcyte's clinical pathology platform is for research use only in some locations. The company provides an AI software platform for clinical pathology that leverages machine learning for quicker, more efficient diagnoses for laboratories and patients. Ralph Yarro has been the CEO since 2013.

Techcyte, Inc. is a world leader in AI-based digital diagnostics for lab medicine. The company is based in Orem, UT and was founded in 2013 by Ralph Yarro and Mohamed E. Salama. Techcyte's clinical pathology AI platform uses deep machine learning to perform automated analysis of whole slide microscopy images, revolutionizing digital diagnostics for human, animal, and environmental clinics and labs. Techcyte's clinical pathology platform is for research use only in some locations. The company provides an AI software platform for clinical pathology that leverages machine learning for quicker, more efficient diagnoses for laboratories and patients. Ralph Yarro has been the CEO since 2013.

Techcyte, Inc. is a world leader in AI-based digital diagnostics for lab medicine. The company is based in Orem, UT and was founded in 2013 by Ralph Yarro and Mohamed E. Salama. Techcyte's clinical pathology AI platform uses deep machine learning to perform automated analysis of whole slide microscopy images, revolutionizing digital diagnostics for human, animal, and environmental clinics and labs. Techcyte's clinical pathology platform is for research use only in some locations. The company provides an AI software platform for clinical pathology that leverages machine learning for quicker, more efficient diagnoses for laboratories and patients. Ralph Yarro has been the CEO since 2013.

NanoSpot ai, Inc is a company that provides a point-of-care and home testing platform using agglutination and artificial intelligence-based interpretation. The company is based in Salt Lake City, UT. The company's innovative test accurately detects the levels of COVID antibodies in just a few minutes, pain-free, and affordably priced. The test allows anyone to access the levels of their COVID antibodies via a phone screen. The company was founded in 2022 by Hans Haecker, Vanessa Redecke, Mark E. Astill. Rian Wendling has been the CEO of the company since 2021.

Techcyte, Inc. is a world leader in AI-based digital diagnostics for lab medicine. The company is based in Orem, UT and was founded in 2013 by Ralph Yarro and Mohamed E. Salama. Techcyte's clinical pathology AI platform uses deep machine learning to perform automated analysis of whole slide microscopy images, revolutionizing digital diagnostics for human, animal, and environmental clinics and labs. Techcyte's clinical pathology platform is for research use only in some locations. The company provides an AI software platform for clinical pathology that leverages machine learning for quicker, more efficient diagnoses for laboratories and patients. Ralph Yarro has been the CEO since 2013.